EX-4.11.5 5 exhibit_4-115.htm EXHIBIT 4.11.5

Exhibit 4.11.5

                   
AMENDMENT OF SOLICITATION/MODIFICATION OF CONTRACT
 
1. CONTRACT ID CODE
 
PAGE OF PAGES
       
1
3
2. AMENDMENT/MODIFICATION NO.
3. EFFECTIVE DATE
4. REQUISITION/PURCHASE REQ. NO.
5. PROJECT NO. (If applicable)
P00005
 
See Block 16C
OS240516
       
6. ISSUED BY
CODE  
ASPR-BARDA
7. ADMINISTERED BY (If other than Item 6)
CODE
ASPR-BARDA01
           
ASPR-BARDA
ASPR-BARDA
       
200 Independence Ave., S.W.
330 Independence Ave, SW, Rm G644
Room 640-G
Washington DC 20201
Washington DC 20201
         
           
8. NAME AND ADDRESS OF CONTRACTOR (No., street, county, State and ZIP Code)
(x)
9A. AMENDMENT OF SOLICITATION NO.
                   
MEDIWOUND LTD 1477616
                 
MEDIWOUND LTD
42 HAYARKON
   
9B. DATED (SEE ITEM 11)
42 HAYARKON
                 
YAVNE     00812
   
x
10A. MODIFICATION OF CONTRACT/ORDER NO.
       
HHSO100201500035C
       
                   
       
10B. DATED (SEE ITEM 13)
       
CODE      1477616
 
 
 FACILITY CODE
 
 
09/29/2015
 
       
11. THIS ITEM ONLY APPLIES TO AMENDMENTS OF SOLICITATIONS
The above numbered solicitation is amended as set forth in Item 14. The hour and date specified for receipt of Offers      ☐ is extended.   ☐ is not extended.
 
Offers must acknowledge receipt of this amendment prior to the hour and date specified in the solicitation or as amended , by one of the following methods: (a) By completing Items 8 and 15, and returning ________ copies of the amendment; (b) By acknowledging receipt of this amendment on each copy of the offer submitted ; or (c) By separate letter or telegram which includes a reference to the solicitation and amendment numbers. FAILURE OF YOUR ACKNOWLEDGEMENT TO BE RECEIVED AT THE PLACE DESIGNATED FOR THE RECEIPT OF OFFERS PRIOR TO THE HOUR AND DATE SPECIFIED MAY RESULT IN REJECTION OF YOUR OFFER. If by virtue of this amendment you desire to change an offer already submitted , such change may be made by telegram or letter, provided each telegram or letter makes reference to the solicitation and this amendment, and is received prior to the opening hour and date specified.
12. ACCOUNTING AND APPROPRIATION DATA (If required)
Net Increase:
$20,784,789.00
See Schedule
   
13. THIS ITEM ONLY APPLIES TO MODIFICATION OF CONTRACTS/ORDERS. IT MODIFIES THE CONTRACT/ORDER NO. AS DESCRIBED IN ITEM 14.
 
CHECK ONE
A. THIS CHANGE ORDER IS ISSUED PURSUANT TO: (Specify authority) THE CHANGES SET FORTH IN ITEM 14 ARE MADE IN THE CONTRACT ORDER NO. IN ITEM 10A.
 
 
 
B. THE ABOVE NUMBERED CONTRACT/ORDER IS MODIFIED TO REFLECT THE ADMINISTRATIVE CHANGES (such as changes in paying office, appropriation date, etc.) SET FORTH IN ITEM 14, PURSUANT TO THE AUTHORITY OF FAR 43.103(b).
 
X
C. THIS SUPPLEMENTAL AGREEMENT IS ENTERED INTO PURSUANT TO AUTHORITY OF:
FAR 1.602-1 and Mutual Agreement of All Parties, FAR Changes Clauses Sections 52.243-02
 
D. OTHER (Specify type of modification and authority)
 
E. IMPORTANT: Contractor ☐ is not.  ☒ is required to sign this document and return      1      copies to the issuing office.
14. DESCRIPTION OF AMENDMENT/MODIFICATION (Organized by UCF section headings, including solicitation/contract subject matter where feasible.)
Tax ID Number:     C0-0000387
DUNS Number:     532040334
PURPOSE of this modification is to:

a) Amend CLIN 0001 and provide additional funding in the amount of $20,784,789 to bring the total to $50,961,423 for CLIN 0001

Funds Obligated Prior to this Modification
$72,096,067
Funds Obligated with mod #05
$20,784,789
Total Funds Obligated to Date
$92,880,856
 
Continued ...
Except as provided herein, all terms and conditions of the document referenced in Item 9 A or 10A, as heretofore changed, remains unchanged and in full force and effect.
15A. NAME AND TITLE OF SIGNER (Type or print)
 16A. NAME AND TITLE OF CONTRACTING OFFICER (Type or print)
   
Sharon Malka, CEO       Yaron Meyer, General Counsel
 MATTHEW A. ROSE
 
15B. CONTRACTOR/OFFEROR
15C. DATE SIGNED
 16B. UNITED STATES OF AMERICA
16C. DATE SIGNED
     /s/Sharon Malka /s/Yaron Meyer MediWound Ltd.     
5/24/2019
                    /s/ Matthew Rose                   
05/24/2019
(Signature of person authorized to sign)
 
(Signature of Contracting Officer)
 
NSN 7540-01-152-8070
STANDARD FORM 30 (REV. 10-83)
Previous edition unusable
Prescribed by GSA
 
FAR (48 CFR) 53.243
 

       
CONTINUATION SHEET
REFERENCE NO. OF DOCUMENT BEING CONTINUED
PAGE OF
HHSO100201500035C/P00005
2
3
NAME OF OFFEROR OR CONTRACTOR
MEDIWOUND LTD 1477616
ITEM NO.
(A)
SUPPLIES/SERVICES
(B)
QUANTITY
(C)
UNIT
(D)
UNIT PRICE
(E)
AMOUNT
(F)
 
Expiration date: July 31, 2023
       
 
(Please see Continuation Sheet)
       
           
 
Except as provided herein, all terms and conditions of the contract remains unchanged Delivery Location Code: HHS/OS/ASPR
       
 
HHS/OS/ASPR
       
 
200 C St SW
       
 
WASHINGTON DC 20201 US
       
           
 
Period of Performance: 09/29/2015 to 07/31/2023
       
           
 
Change Item 1 to read as follows(amount shown is the obligated amount):
       
           
 1
ASPR-15-08828 -- CLIN 0001 Advanced development studies for NexoBrid
     
20,784,789.00
           
 
Delivery: 10/05/2015
       
 
Amount: $23,955,661.00
       
 
Accounting Info:
       
 
2015.1990002.26201 Appr. Yr.: 2015 CAN: 1990002 Object Class: 26201
       
 
Funded: $0.00
       
           
 
Delivery: 07/10/2017
       
 
Amount: $6,220,973.00
       
 
Accounting Info:
       
 
2017.1990007.25106 Appr. Yr.: 2017 CAN: 1990007 Object Class: 25106
       
 
Funded: $0.00
       
           
 
Delivery: 05/12/2019
       
 
Amount: $20,784,789.00
       
 
Accounting Info:
       
 
2019.1990051.25106 Appr. Yr.: 2019 CAN: 1990051 Object Class: 25106
       
 
Funded: $20,784,789.00
       
           
           
NSN 7540-01-152-8067
OPTIONAL FORM 336 (4-86)
 
Sponsored by GSA
 
FAR (48 CFR) 53.110
 

Contract Number HHSO100201500035C
page 3 of 3
Modification No: 05
 
 
(Continuation Sheet)

Continuation Sheet
 
 
Contract No: HHSO100201500035C
Modification No: 05
 
 

The purpose of this Modification is to:

A.
ADD SUPPLEMENTAL FUNDS TO BASE CLIN 0001

The contract is revised as follows to:

1.
Amend CLIN 0001 and provide additional funding in the amount of $20,784,789 to bring the total to $50,961,423
2.
Update Section B.3 in accordance with Contractor’s proposal by replacing the CLIN 0001 with the table below :
 
CLIN
Period of
Performance
Supplies/Services
Total Est. Cost
Fixed Fee
(7%)
Total Cost Plus
Fixed Fee
CLIN 0001
09/28/2015-11/15/2022
Licensure, approval, and clearance of product through the FDA
$47,893,883
$3,067,540
$50,961,423 (Funded)
 
Total value of Contract before MOD 05 is $72,096,067

Total value of Contract after MOD 05 is $92,880,856

All other terms and conditions of the contract HHSO201500035C remain unchanged.

[End of Modification No. 05 and the remainder of this page intentionally left blank]